Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma MultiformeFiliz Senbabaoglu, Tugba Bagcı-Önder, Ahmet Cingöz et al.|Cancer Biology & Therapy|2016Cited by 35
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Mehmet Gönen et al.|Cell Communication and Signaling|2023Cited by 12
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancerOzlem Yedier-Bayram, Tugba Bagcı-Önder, Ahmet Cingöz et al.|Experimental & Molecular Medicine|2025Cited by 4
DDIS-04. MITOXANTRONE POTENTIATES TRAIL-INDUCED APOPTOSIS IN GLIOBLASTOMA MULTIFORMEFiliz Senbabaoglu, Tugba Bagcı-Önder, Ahmet Cingöz et al.|Neuro-Oncology|2016Cited by 0
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Ezgi Yağmur Kala et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0